We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

558 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2016 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $37.9M | Put options by funds: $23.6M

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

22% more funds holding in top 10

Funds holding in top 10: 9 → 11 (+2)

21% more capital invested

Capital invested by funds: $9.29B → $11.2B (+$1.95B)

3.82% more ownership

Funds ownership: 93.85% → 97.66% (+3.8%)

4% more repeat investments, than reductions

Existing positions increased: 205 | Existing positions reduced: 197

0% more funds holding

Funds holding: 557 → 558 (+1)

Holders
558
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
14.89%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.29%
New
52
Increased
205
Reduced
197
Closed
41
Calls
$37.9M
Puts
$23.6M
Net Calls
+$14.3M
Net Calls Change
+$1.29M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$685M
2
Victory Capital Management
Victory Capital Management
Texas
+$95.2M
3
American Century Companies
American Century Companies
Missouri
+$77.8M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$74.6M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$54.9M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$229M
2
Royal London Asset Management
Royal London Asset Management
United Kingdom
-$188M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$70.2M
4
HM
HealthCor Management
New York
-$53.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$52.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Victory Capital Management
26
Victory Capital Management
Texas
$102M +$95.2M +1,250,766 +15,646%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$102M -$1.55M -20,308 -2%
BG
28
BlackRock Group
United Kingdom
$102M +$4.29M +56,294 +5%
HM
29
HealthCor Management
New York
$93.6M -$53.3M -700,000 -38%
Deutsche Bank
30
Deutsche Bank
Germany
$90.4M -$4.1M -53,851 -5%
FC
31
Fairpointe Capital
Illinois
$90.1M -$37.9M -497,253 -31%
RRAM
32
River Road Asset Management
Kentucky
$85.3M -$22.6M -296,567 -22%
Fidelity Investments
33
Fidelity Investments
Massachusetts
$81.9M +$3.4M +44,601 +5%
Franklin Resources
34
Franklin Resources
California
$77.2M +$64.7K +850 +0.1%
Westfield Capital Management
35
Westfield Capital Management
Massachusetts
$67.9M -$2.9M -38,053 -4%
Legal & General Group
36
Legal & General Group
United Kingdom
$60.1M +$1.68M +22,110 +3%
Acadian Asset Management
37
Acadian Asset Management
Massachusetts
$59.2M +$54.9M +721,239 +12,923%
Ameriprise
38
Ameriprise
Minnesota
$58.9M -$6.95M -91,217 -11%
Canada Life
39
Canada Life
Manitoba, Canada
$56.9M +$225K +2,949 +0.4%
APG Asset Management
40
APG Asset Management
Netherlands
$50.7M +$9.43M +123,800 +25%
GC
41
Guggenheim Capital
Illinois
$49.9M -$7.85M -103,145 -14%
PFC
42
Poplar Forest Capital
California
$48.8M -$5.19M -68,221 -10%
BCM
43
Bridgeway Capital Management
Texas
$48.5M +$45.4M +595,800 New
Marshall Wace
44
Marshall Wace
United Kingdom
$48.5M +$45.4M +595,601 New
TCIM
45
TIAA CREF Investment Management
New York
$45.4M +$12.2M +159,572 +40%
CIC
46
Crawford Investment Counsel
Georgia
$43.8M -$912K -11,971 -2%
RJA
47
Raymond James & Associates
Florida
$43.5M +$1.7M +22,367 +4%
Massachusetts Financial Services
48
Massachusetts Financial Services
Massachusetts
$43M +$1.69M +22,173 +4%
First Trust Advisors
49
First Trust Advisors
Illinois
$42.5M -$8.69M -114,146 -18%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$42.1M +$5.48M +72,000 +16%
1
2
3 4 5

DGX Hedge Fund Activity: Q2 2016 in Review

558 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2016, worth a combined $11.2B — up 21% from $9.29B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new DGX positions and 41 closed out — a net gain of 11 holders — while 205 added to existing stakes and 197 trimmed.

The largest buyer was Macquarie Group, adding an estimated $685M. The largest seller was T. Rowe Price Associates, cutting an estimated $229M.

  • 558 institutional investors held Quest Diagnostics (DGX) as of Q2 2016, up from 557 in Q1 2016.
  • Funds reported $11.2B of Quest Diagnostics stock for Q2 2016, up 21% quarter-over-quarter.
  • 52 funds opened new Quest Diagnostics positions in Q2 2016 and 41 closed out, a net change of +11 holders.
  • The largest Quest Diagnostics buyer in Q2 2016 was Macquarie Group, an estimated $685M added.
  • The largest Quest Diagnostics seller in Q2 2016 was T. Rowe Price Associates, an estimated $229M sold.

Based on aggregated 13F filings for Q2 2016.